• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症周围神经的超常期改变

Altered supernormality in multiple sclerosis peripheral nerve.

作者信息

Eisen A, Paty D, Hoirch M

出版信息

Muscle Nerve. 1982 May-Jun;5(5):411-4. doi: 10.1002/mus.880050513.

DOI:10.1002/mus.880050513
PMID:6289099
Abstract

Supernormality is a regular part of the recovery cycle of nerve. Supernormality was expressed in terms of amplitude, and in 20 control subjects the mean (S2 conditioned/S2 unconditioned) ratio of the median sensory nerve action potential amplitude recorded at the elbow measured 285 +/- 174 (range 119 to 783). A supramaximal conditioning shock was delivered 6 msec in advance of the test pulse. Seventeen (42.5%) of 40 patients with multiple sclerosis (MS) failed to demonstrate supernormality, the (S2 conditioned/S2 unconditioned) ratio being less than 100. This abnormality probably reflects a delay in recovery cycle and is additional evidence implicating peripheral nervous system involvement in multiple sclerosis.

摘要

超常期是神经恢复周期的正常组成部分。超常期通过振幅来表示,在20名对照受试者中,在肘部记录的正中感觉神经动作电位振幅的平均(条件刺激S2/非条件刺激S2)比值为285±174(范围为119至783)。在测试脉冲提前6毫秒施加超强条件刺激。40例多发性硬化症(MS)患者中有17例(42.5%)未表现出超常期,(条件刺激S2/非条件刺激S2)比值小于100。这种异常可能反映了恢复周期的延迟,是提示多发性硬化症累及周围神经系统的额外证据。

相似文献

1
Altered supernormality in multiple sclerosis peripheral nerve.多发性硬化症周围神经的超常期改变
Muscle Nerve. 1982 May-Jun;5(5):411-4. doi: 10.1002/mus.880050513.
2
Alteration of motor nerve recovery cycle in multiple sclerosis.多发性硬化症中运动神经恢复周期的改变。
Clin Neurophysiol. 2007 Aug;118(8):1753-8. doi: 10.1016/j.clinph.2007.04.025. Epub 2007 Jun 18.
3
Peripheral sensory abnormalities in patients with multiple sclerosis.多发性硬化症患者的周围感觉异常
Muscle Nerve. 1992 Jan;15(1):73-6. doi: 10.1002/mus.880150113.
4
[Medullar and supraspinal conduction in multiple sclerosis: localization value (author's transl)].[多发性硬化症的脊髓和脊髓上传导:定位价值(作者译)]
Med Clin (Barc). 1980 Mar 10;74(5):183-7.
5
[Detection of subclinical sensory nerve dysfunction in amyotrophic lateral sclerosis--a microneurographic study].
No To Shinkei. 1995 Apr;47(4):345-8.
6
Central and peripheral conduction times in multiple sclerosis.多发性硬化症的中枢和外周传导时间
Electroencephalogr Clin Neurophysiol. 1980 Mar;48(3):253-65. doi: 10.1016/0013-4694(80)90263-1.
7
Features of central and peripheral nerve conduction in demyelinating diseases and specific neuropathies in Japan.日本脱髓鞘疾病和特定神经病变中中枢和周围神经传导的特征。
Electroencephalogr Clin Neurophysiol Suppl. 1982;36:111-25.
8
Different mechanisms underlying changes in excitability of peripheral nerve sensory and motor axons in multiple sclerosis.多发性硬化症中周围神经感觉和运动轴突兴奋性变化的不同机制。
Muscle Nerve. 2013 Jan;47(1):53-60. doi: 10.1002/mus.23455. Epub 2012 Nov 21.
9
Somatosensory evoked potential testing in multiple sclerosis.多发性硬化症中的体感诱发电位测试。
Adv Neurol. 1981;31:183-99.
10
[Study on the latency difference between compound muscle and sensory nerve action potentials].[复合肌肉动作电位与感觉神经动作电位潜伏期差异的研究]
No To Shinkei. 2001 Jun;53(6):541-5.

引用本文的文献

1
Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis.多发性硬化症患者外周神经系统变化的电诊断评估
Malays J Med Sci. 2013 Jul;20(4):32-8.
2
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.外周神经的强度-持续时间时间常数:多发性硬化症无异常。
Mult Scler Int. 2012;2012:390157. doi: 10.1155/2012/390157. Epub 2012 May 8.
3
Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation.多发性硬化症中血液和脑脊液生物标志物的动态变化:对数据解读的启示
Mult Scler Int. 2011;2011:823176. doi: 10.1155/2011/823176. Epub 2011 Apr 14.
4
The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.多发性硬化症研究的悲惨现状(事实少,虚构多):支持其为神经嵴病变的关键数据。
Inflammopharmacology. 2010 Dec;18(6):265-90. doi: 10.1007/s10787-010-0054-4. Epub 2010 Sep 24.